Skip to main content

Advertisement

Log in

Long-term results of endoscopic treatment of vesicoureteral reflux with the sub-ureteric injection of calcium hydroxyapatite

  • Original article
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Aim

To review our long-term results of the sub-ureteric injection of calcium hydroxyapatite in the endoscopic management of vesicoureteral reflux (VUR) in children.

Materials and methods

A sub-ureteric injection of calcium hydroxyapatite was given to 14 children (23 ureteral units) affected by VUR grades I–V. All children were followed-up with monthly urine cultures, and a renal ultrasound was done on the postoperative 4th week, while the first voiding cysto-urethrogram (VCUG) control was performed on postoperative week 12. The children were followed-up with yearly renal ultrasound and monthly urine cultures, thereafter. Data from the patients’ charts were retrospectively analyzed regarding the outcome of the procedures.

Results

Mean follow-up time was 52 months (47–60 months). VUR was cured in 47.4% of cases after a single injection. After the second injection the global success rate was 52.1%. Ureteroneocystostomy was performed on seven refluxing ureters of five children unresponsive to sub-ureteric injection therapy. One patient underwent nephroureterectomy because of a non-functioning kidney secondary to ureteral obstruction due to migration of material at the 23rd month postoperatively.

Conclusion

Although favorable short-term success rates have been reported with the sub-ureteric injection of calcium hydroxyapatite without any side effects, our long-term results showed a low success rate, with the only reported serious morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Matouschek E (1981) Treatment of vesicorenal reflux by transurethral Teflon injection (in German). Urologe A 20(5):263–264

    PubMed  CAS  Google Scholar 

  2. O’Donnell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux. Br J Urol 58(6):601–604

    Article  PubMed  CAS  Google Scholar 

  3. Tarcan T, Şimşek F, Akdaş A (1995) A review of injectable materials in the endoscopic treatment of vesicoureteral reflux. Marmara Med J 9:43–47

    Google Scholar 

  4. Mayer R, Lightfoot M, Jung I (2001) Preliminary evaluation of calcium hydroxyapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57(3):434–438

    Article  PubMed  CAS  Google Scholar 

  5. Mevorach RA, Hulbert WC, Rabinowitz R, et al (2006) Results of a 2-year multicenter trial of endoscopic treatment of vesicoureteral reflux with synthetic calcium hydroxyapatite. J Urol 175(1):288–291

    Article  PubMed  Google Scholar 

  6. Eryildirim B, Tarhan F, Kuyumcuoğlu U, et al (2006) Endoscopic subureteral injection treatment with calcium hydroxyapatite in primary vesicoureteral reflux. Int Urol Nephrol [Epub ahead of print]

  7. Önol FF, Tarcan T, Tinay I, et al (2006) Kidney loss due to periureteral fibrosis and ureteral obstruction secondary to migration of subureterically injected calcium hydroxylapatite. J Pediatr Urol 5:503–508

    Article  Google Scholar 

  8. Şimşek F, Ilker Y, Akdaş A, et al (1991) Teflon injection in the treatment of vesicoureteral reflux: a promising alternative for surgery. Int Urol Nephrol 23:27–30

    Article  PubMed  Google Scholar 

  9. Winter AL, Hardy BE, Alton DJ, et al (1983) Acquired renal scars in children. J Urol 129(6):1190–1194

    PubMed  CAS  Google Scholar 

  10. Malizia AA, Reiman HM, Myers RP, et al (1984) Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251(24):3277–3281

    Article  PubMed  Google Scholar 

  11. Schulman CC (1992) A new uroimplant for endoscopic correction of reflux. American Academy of Pediatrics, San Francisco, 10–15 October 1992

  12. Smith P, Kaplan WE (1991) Evaluation for polydimethylsiloxane as an alternative in endoscopic treatment of vesicoureteral reflux. AUA, North Central Section Meeting, Scottsdale, AZ, 4–9 November 1991

  13. Sanger JR, Matloub HS, Yousif NJ, et al (1992) Silicone gel infiltration of a peripheral nerve and constrictive neuropathy following rupture of a breast prosthesis. Plast Reconstr Surg 89(5):949–952

    Article  PubMed  CAS  Google Scholar 

  14. Puri P, Pirker M, Mohanan N, et al (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176(2):1856–1859

    Article  PubMed  CAS  Google Scholar 

  15. Stenberg AM, Sundin A, Larsson BS, et al (1997) Lack of distant migration after injection of 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158(5):1937–1941

    Article  PubMed  CAS  Google Scholar 

  16. Henly DR, Barrett DM, Weiland TL, et al (1995) Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 153(6):2039–2043

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tufan Tarcan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarcan, T., Tinay, I., Temiz, Y. et al. Long-term results of endoscopic treatment of vesicoureteral reflux with the sub-ureteric injection of calcium hydroxyapatite. Int Urol Nephrol 39, 1011–1014 (2007). https://doi.org/10.1007/s11255-007-9222-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-007-9222-x

Keywords

Navigation